Hydroxymethylglutaryl-coenzyme a reductase inhibition stimulates caspase-1 activity and Th1-cytokine release in peripheral blood mononuclear cells
Additionally, there are other medications that may exacerbate OSA and theoretically worsen daytime sleepiness, such as: Benzodiazepine receptor agonists Barbiturates Antiepileptic medications Sedating antidepressants such as mirtazapine (antidepressants can cause weight gain, which worsens sleep apnea due to obesity) Antihistamines Opiates Various medications have been studied for treating obstructive sleep apnea, including drugs that stimulate the respiratory system (directly like theophylline, or indirectly like acetazolamide), drugs that reduce risk of upper airway collapse (desipramine), antimuscarinic drugs (oxybutynin), and noradrenergic drugs (atomoxetine), but none of them have yet shown a significant ability to reduce OSA
I.KhakuS.et al
Only one SAM binding site is observed in CBS filaments Each Bateman module, assembled from the tandem CBS-1 and CBS-2 motifs, contains, in principle, two ligand-binding sites (S1 and S2) related by dyad symmetry (Supplementary Fig
Thus, this underscores the need for next-generation subunit vaccines that elicit durable humoral and cellular immune responses ( Subunit vaccines, despite their excellent safety profile, often require potent adjuvants to enhance immunogenicity and achieve a sustained protective response against intracellular pathogens ( Recently, the role of B cells as non-canonical APCs has been recognized as crucial in prolonging the immunity following the repeated immunization ( Collectively, the present work explored the potential of a dual-adjuvant approach to induce durable and functionally active antigen-specific humoral responses against two pivotal Plasmodium liver-stage antigens, Pf CSP and Pb SLTRiP ( Materials and methods BALB/c and C57BL/6 mice, aged 68 weeks, were procured from Zydus Research Centre, Ahmedabad, India
